Remimazolam besylate approved for use in the UK for procedural sedation

Approval of this ultra-short acting anaesthetic is based on data from a US-based Phase III clinical trial programme in procedural sedation, evaluating the anaesthetic in patients undergoing bronchoscopy or colonoscopy.

Source:

PharmaTimes